The developments in printing technologies allow fabrication of micron-size nano-layered delivery systems to personal specifications. In this study we fabricated layered polymer structures for drug-delivery into a microfluidic channel and aimed to interferometrically assure their topography and adherence to each other. We present a scanning white light interferometer (SWLI) method for quantitative assurance of the topography of the embedded structure. We determined rapidly in non-destructive manner the thickness and roughness of the structures and whether the printed layers containing polymers or/and active pharmaceutical ingredients (API) adhere to each other. This is crucial in order to have predetermined drug release profiles. We also demonstrate non-invasive measurement of a polymer structure in a microfluidic channel. It shown that traceable interferometric 3D microscopy is a viable technique for detailed structural quality assurance of layered drug-delivery systems. The approach can have impact and find use in a much broader setting within and outside life sciences.
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T echnology allows developing and fabricating pharmaceuticals in a tailored and personalized manner to meet the needs of individuals and patient groups [1] [2] [3] . The challenge is to deliver the benefits of this work to patients. Personalized medicine relies on diagnostic/genetic testing and targeted drug delivery. In addition our vision of future personalized medicine also entails flexible fabrication to allow accurate dosing of medicines. Personalized medicines can be e.g. produced by a scalable technology based on precise and robust 3D printing. Real-time quality control of the functionality of these drug delivery systems would be important and desirable.
A small, multi-layered, polymer structure can allow precisely controlled drug release in time and space with a carefully engineered release profile 4, 5 . It can allow several active pharmaceutical ingredients to be released in temporal sequence. To assure the functionality of such a structure the thickness of the different layers should be tightly controlled, the layers need to adhere to each other, and the surface of the outermost layers must be intact 6 . The absolute measurement precision must be high because the layers are thin and because the drug release depends on layer thickness 7 and layer roughness 8 . The quality assurance method should be sterile and noncontacting to avoid contamination and altering the surface.
Our proposed contribution to personalized medicine is a method that combines 3D printing, 3D scanning white light interferometry (SWLI), and microfluidics to enable engineering and control of drug release profiles. Each of these three primary methods already alone provides impact. 3D printing gives reproducible otherwise unobtainable release profiles (it also permits high spot density, small volume spots and microarrays) 9 , SWLI provides non-contact, real time and non-invasive structural inference that can be metrologically traceable. Microfluidics can provide a clinically relevant and controllable, small volume environment where temperature and (bio)chemistry can be rapidly changed 10 .
In drug design and development one needs to control the properties of drug substances and additives in addition to enhancing and controlling their delivery and release 3, 6 . Printing drugs allow fabricating structured and tailored drug-delivery systems. One can use topology (e.g. thickness and surface roughness of the printed layers) and chemical concentration to engineer their release profile 6 . These systems can be produced to tight specifications. Since material can be deposited accurately (space and amount) printed drugs with predetermined release profiles can potentially carry low drug concentrations. Quality assurance of printed products remains a challenge 2, 4 . 2D and 3D printing permits fabricating functional structures of metals, polymers, and biomaterials 11, 12 . 3D structures can be printed on a variety of surfaces with characteristic permeability, porosity, hydrophobicity/ hydrophilicity and surface energy. This allows controlling the properties of the printed substances. Besides accurate patterning, printing on tailored functionalized substrates and multi-layer printing makes automated high-speed manufacture of complex structures possible. It opens up new avenues for tailoring physicochemical properties of organic substances.
There are few non-contacting and non-destructive ways to measure, in a traceable manner, surface roughness, thickness and adhesion of layers. Optical confocal microscopy provides sub-micron resolution along the z-direction (into the sample) but is disadvantageous for large area scanning. Moreover, it employs intense laser light, which may alter the mechanical and chemical properties of drug-laden polymers. Measuring inside a microfluidic channel is hard 13 . LED-based optical coherence tomography (OCT) even though a point-by-point method, fulfills many of the above requirements but its precision in determining the thickness of thin layers may be insufficient 14 . Ultra-sound microscopy especially used in second harmonic mode 15 provides qualitative images but seldom allows one to quantitatively determine the strength of adhesion or the size of disbonds along the z-direction. Moreover it can't deal with gas-filled voids and usually requires acoustic couplants that may modify the sample. Terahertz imaging can infer about layered structures but does not provide sufficient quantitative spatial precision along the z-direction 8 . Nano-scale x-ray tomography potentially offers sufficient precision but is impractical since it is slow and uses ionizing radiation 16 . None of these methods fulfill the requirements presented by the current case (personalized drugs produced at pointof-care). Non-contacting, rapid, and non-destructive SWLI allow the possibility to determine surface roughness, the geometric thickness of layered structures, the adherence between the layers, and the thickness of each individual layer 17 . Here we report the first implementation of scanning white light interferometry to study these features of layered drug-delivery systems.
Results
Our custom-built SWLI optically compensates for the thickness of the roof in the microfluidic channel ( Fig. 1 ) and measures the effective refractive index of the drug-laden structure (Fig. 2) . The SWLI method provides 10-20 nm traceable resolution along the z-dimension. This potentially sterile technique requires no sample preparation. Using image stitching it allows, when necessary, high resolution also across a large surface (up to 2003) 18 Moreover, it can determine surface roughness Sq (ISO 25178) for an embedded surface without direct tactile access. It can measure stacked layers that are static or moving 19 . SWLI measures the optical path difference between the reference and sample arm of the interferometer. When the sample is in air and we measure the step height -the single layer thickness -there are two interferences one for the base surface (Point A1, Fig. 1 ) and one for the top surface of the layer (Point B2, Fig. 1 ). The distance between these two interferences is equal to the layer thickness directly. When we measure through a well bonded layer there are also two interferences, but the position of the second one is shifted (Point B3, Fig. 1 ), compared to the interference at the base surface (Point A1, Fig. 1 ) because the optical thickness is equal to the geometrical thickness multiplied by the refractive index of the layer. The shift of the second interference depends of the refractive index of the layer (case B in the figure). The ratio between geometrical and optical thicknesses is equal to the refractive index of the layer. In the case of an unbonded or missing part of the layer a third interference appears between the first and second one (case C in the figure) and the shift of the last interferogram (Point C6, Fig. 1 ) depends of the thickness of the nonbonded layer.
To demonstrate the capacity of our proposed method a multi-layer drug-delivery system containing the vitamin B2, riboflavine sodium phosphate (RSP), is shown in Fig. 3a . Samples featuring these crossing lines of HPMC and RSP were placed on glass microscope cover slips. The image is 1 mm 2 . We prepared relevant test samples using a technique that simulated printing as described in 5 . The transparent HPMC lines were on average 3.98 mm thick and 5-10 mm wide whereas the RSP lines were on average 26 mm thick. The roughness of the HPMC (Sq1) was 0.58 mm and RSP (Sq2) 0.46 mm 2 . Figure 3a shows a disbonded HPMC-RSP multilayer system featuring air filled voids 0.15-30 mm tall. Figure 3b illustrates both adhered and disbonded multi-layer systems of hydroxypropylcellulose (HPC) film on a PET (polyethylene terephthalate) surface. These images show high resolution top surface topography with roughness of 0.31 mm (Sq1) and an apparently rougher second surface (light dispersion by the top surface makes it appear rougher than it is). Single camera pixel data ( Fig. 3a and 3b , leftmost) and a 3D surface plot of the polymer layer are shown ( Fig. 3a and 3b, middle) . The images were reconstructed pixel by pixel from the interferogram. The depth coordinate of each layer was extracted using Larkin's algorithm 20 . Fig. 2 shows how the geometric thickness of a structure can be determined even though its refractive index is not known in advance. The SWLI measures optical thickness d opt . The geometric thickness (d g ) of the polymer layer is A1-B3 since the refractive index of air 5 1. The effective refractive index of the adhered layer is (B3 -B4)/(A1 -B3). The same approach can be used to determine both layer thickness and disbond height. Except for the top layer the depth coordinate was corrected using the refractive index. This index was obtained by relying on a discontinuity in the structure, see Fig. 3a . The interferograms from a point on the top layer and from a corresponding point on the bottom surface on that layer are separated on average by d opt 5 6.23 mm whereas the discontinuity on bottom surface is known to be 2.25 mm tall which indicates an estimated layer thickness of 3.98 mm. The height of the disbonds was determined by assuming that the refractive index of the disbond was 1.00. Figure 4 shows a polymer structure measured inside a microfluidic channel during 8 ml/min (1.8 mm/s) water flow. It took a few minutes to obtain the images in Fig. 3 and 4 . These images were automatically analyzed by commercial and custom made software to construct and analyze 3D images of the cross-over point of the two crossing strips. The standard uncertainty for the z-coordinate in the construct was 0.045 mm. We assumed the refractive index of water to be 1.33.
Discussion
The proposed method rapidly determined the structure and presence of disbonds in the printed drug-delivery system. There are limitations to the method. A layer separation, of less than 0.5 mm or more than a few millimeters is hard to image. When the number of interfaces exceeds four it is hard to automatically extract the layers. The employed technique to derive the effective refractive index may not always work well. One example is high throughput analysis of systems with different drugs, another example is if the drug concentration exhibits a gradient inside a layer. Finally, the Sq value has not yet been linked in a traceable manner to a common surface roughness index such as Rq.
We presented for the first time a practical method for traceable structural quality assurance of printed drug delivery systems. This result opens up a plethora of opportunities to induce quality assured fabrication in the field of tissue engineering, microfluidics, bio-MEMS, metamaterials, as well as nano-and micro-sized layered structures in addition to printed pharmaceuticals.
This traceable quantitative method can provide a competitive edge to both research and production carried out in academia and the industry. In practice one can carry out high throughput label-free testing, one can optimize products structurally, and one can assess systems in wet and dry environments. The method has high spatial and temporal precision, and can be applied in a controlled microfluidic environment. It can allow structural and functional quality assurance for a broad range of applications in life sciences.
Methods
Scanning white light interferometry (SWLI). The samples were imaged using a custom-made SWLI instrument, Fig. 2 . Briefly, the instrument uses a halogen lamp (Osram G4, driven at 6 Volts, 10 W), a standard 53 Michelson Nikon objective (Nikon CF IC Epi Plan TI; Japan) or 103 Mirau objective (Nikon CF IC Epi Plan DI; Japan), and a piezo translator with 100 mm travel (Physik Instrumente -type P-721.CDQ). The system magnification was 3.15 with the Michelson objective and 6.3 with the Mirau objective. The instrument can determine profiles with 615 nm accuracy along the z-direction. A detailed description of the VIS interferometer is given in 17 . In the receiving part we employed a 3.63 mm pixel size black and white camera (Hamamatsu C11440 Orca Flash2.8, Hamamatsu City, Japan).
We validated the SWLI for top surface imaging by inspecting a standard sample VLSI 1853 6 2.3 Å (model #SHS-1800 QC, VLSI Standards, Inc.). Traceability to the national SI standard is ensured using a transfer artifact. The influence of the roof of the channel was removed with a compensating plate identical to the 200 mm thick cover glass (CLS2960246, Sigma-Aldrich, Corning) of the microfluidic channel inserted into the reference arm of the interferometer.
Microfluidic channels. The cover glass and 1000 mm thick microscope base glass were used (Menzel Microscope slides, ISO 8037/1) to construct the microfluidic channels. Inlet and outlet holes (2 mm in diameter) were drilled in the base glass. Plastic tubing (TubPEEK Blu 1/16 Z226661) was attached by UV cured glue (Thorlabs NOA81). The tubes were leveled to the base glass. A 2 mm wide channel was created using two-sided 50 mm thick double-sided tape (Tesa) between the cover and base glass. The sample was placed in the middle of the channel. The cover glass was then attached. Ion-exchanged water was flowed through the channel with a pump (Alladdin-1000, World precision Instruments, Aston, Stevenage, UK).
Sample preparation. There were four kinds of samples. The films were created by solvent casting using a manual pipette (BioHit ProLine 1 Mech, Finland) simulating printing of drug substances and polymers as described in 2 . All samples were dried in ambient conditions (21uC and 40% RH). The aqueous solutions for Figure 3 membranes consisted either of 2 mg/ml riboflavin sodium phosphate (RSP, riboflavin 59-monophosphate sodium salt, Ph. Eur., Fluka Analytical, Sigma-Aldrich, France) in 1% (w/w) hydroxypropyl methylcellulose (HPMC, Metolose 90SH-4000, Shin-Etsu, Tokyo, Japan) or pure 1% HPMC solution. The sample presented in Figure 4 | Left: (a) Interferograms and reconstructed SWLI image of printed ethylcellulose polymer film drug-delivery system imaged inside a microfluidic channel during 8 ml/min water discharge. Indicated: DDS surfaces (top surface and bottom surface). The single camera pixel datainterferograms, were obtained for the corresponding points on the layers. Using the method outlined in Figure 1 we determined the refractive index (n 5 1.47 6 0.02), the average thickness (44.0 mm) of the structure, and the average height of the disbond (5.7 mm). The Sq in the indicated area is 0.30 mm. Right: (b) The imaged structure.
www.nature.com/scientificreports SCIENTIFIC REPORTS | 4 : 4020 | DOI: 10.1038/srep04020 Figure 3a was a three-layer construct (HPMC/RSP-HPMC/HPMC, from top to bottom) prepared on a water impermeable polyethylene terephthalate (PET) film (MylarH A, Dupont Teijin Films Europe, Luxembourg). The sample in Figure 3b was a two-layer construct with hydroxypropylcellulose (HPC, Klucel LF, Shin-Etsu, Tokyo, Japan) residing on a PET surface (HPC/PET, from top to bottom). The HPC film was prepared by deposition of 1% HPC solution on top of the PET surface. The solution to fabricate the film for the sample in Fig. 4 contained water insoluble ethylcellulose (EC, E8003, Sigma-Aldrich, USA; ethoxy content, 48-49.5%; viscosity, 45 cP) and ethanol ($96.1%, Etax A, Altia OYj, Finland). The EC sample was placed in a microfluidic channel for measurement. Fig. 2 depicts a three-layer construct (theophylline-HPC/HPMC/PET, from top to bottom). The solutions to create these double-layer membranes contained 7 mg/ml theophylline in 3.3% (w/w) hydroxypropylcellulose (HPC, in ethanol) (top layer) and 1% HPMC (in water) (second layer). These two layers were made on top of a PET surface. Incisions through the double-layer membrane were made to remove a section of the system to allow determining the film thickness and its attachment to the PET-base in Fig. 2 .
Image reconstruction and processing. We scanned the samples with our custommade SWLI instrument. Images were acquired with 68.75 nm vertical spacing. At each height we averaged 10 camera frames after which we recorded both the average image and the height coordinate output by the calibrated piezo capacitive sensor.
Surfaces were reconstructed using Larkin's algorithm 7 on a higpass-filtered SWLI signal. This modification permitted us to do multi-surface feature extraction. Shortly: the single pixel camera intensity data vector (stacked pixels) was high-pass filtered with a second order derivative filter. The algorithm then identified and stored the maximum of the envelope of the interferences in the filtered vector. The interactive multi-interface extraction process first asked for the maximum number of interfaces to extract, and for the minimum permissible threshold value for envelope maxima and interface separation. For each 3D image the threshold value was found by an iterative procedure. (In Fig. 2 the HPC Theophyllin -HPMC interface was found by pooling 25 pixels prior to extracting envelope maxima. Extracted interfaces were filtered using first a 3 3 3 pixel filter and then a 7 3 7 pixel median filter along the x-y direction. Surface height data was corrected from optical height to geometric height using the method illustrated in Fig. 2 . In practice, planes were fitted in least squares sense to the reference surfaces #1 and #3 in the above figure. The distance between these planes was determined analytically. Local surface fitting (second or third order in x and y) was used to patch small areas lacking data. These areas were identified and the size of the patch was decided manually post hoc. The final 3D image was tiltcorrected by requiring that the bottom most interface was horizontal.The Sq parameter was determined from unfiltered surface data as outlined in ISO25178.
